News Archives - OIS

latest news

Devices and Diagnostics / News

How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

Steve Lenier / August 20, 2019

Deals / News

A Closer Look at Glaukos’ Bid for Avedro

News

OIS@ASRS Reporter’s Notebook: Three Things Learned at OIS@ASRS About What Funders Want, Going Global, and AI

Devices and Diagnostics / News

Recent Moves Show How Zeiss Is Positioning Itself for a New Era in Ophthalmology

Digital / News

National Vision and Eye Health Surveillance System Gears Up for September Launch

Pharmaceuticals

OIS@ASRS at the Ritz-Carlton Chicago: An In-depth Look at the Retina Space

OIS@ASRS at the Ritz-Carlton Chicago: An In-depth Look at the Retina Space

July 17, 2019

Ocular Therapeutix’s Strong Bounce Back

After Re-submitted NDA a Year Ago, Ocular Therapeutix Finds Its Path Forward

June 19, 2019

Novartis’ New Head of Ophthalmology Lays Out Lofty Goals Days Before Xiidra Deal

Novartis’ New Head of Ophthalmology Lays Out Lofty Goals Days Before Xiidra Deal

May 14, 2019

Protocol V, LEAVO Among Retina Highlights at ARVO

Protocol V, LEAVO Among Retina Highlights at ARVO 2019

May 1, 2019

Will Dexycu’s Cost Inhibit Its Use?

Will Dexycu’s Cost Inhibit Its Use?

April 10, 2019

1
2
3
…
21
Next »

devices & diagnostics

$How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule$

How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

August 20, 2019

Recent Moves Show How Zeiss Is Positioning Itself for a New Era in Ophthalmology

Recent Moves Show How Zeiss Is Positioning Itself for a New Era in Ophthalmology

August 1, 2019

ASCRS 2019

Reporter’s ASCRS Notebook: Five Things in Dry Eye, MIGS, Imaging, and Mydriatics

June 5, 2019

Four Imaging and Diagnostic Platforms Making the Move Toward More Individualized Treatment

May 22, 2019

A Dozen Takeaways from OIS@ASCRS 2019

A Dozen Takeaways from OIS@ASCRS 2019

May 8, 2019

1
2
3
…
15
Next »

OIS Index Opthalmology Innovation Summit Publicly Traded Growth Companies

stay connected

Register for Opthalmology Innovation Summit OIS@AAO October 19, 2019 in San Francisco, California.

NEXT OIS EVENT

OIS-Presenting-Companies-AD-CTA-2-8-17

MEET THE OIS@ASRS
ADVISORY BOARD

Timothy Murray

Timothy G. Murray, MD

Timothy G. Murray, MD, MBA is currently the Founding Director/CEO of Ocular Oncology and Retina…

Read More

Christina Weng

Christina Weng, MD

Christina Y. Weng, MD, MBA is an Associate Professor of Ophthalmology and the Vitreoretinal Diseases…

Read More

John Pollack

John Pollack, MD

Illinois Retina Associates

Read More

Rahhal Firas

Firas M. Rahhal, MD

ExSight Ventures

Read More

about ois

OIS

The OIS programs are presented annually by Healthegy, Inc. as affiliate meetings with AAO, ASCRS, SECO, and ASRS.

Learn more about our world-class conferences.

latest videos

GenSight Biologics - Innovation Showcase at Ophthalmology Innovation Summit @ ASCRS 2019

GenSight Biologics – Innovation Showcase at Ophthalmology Innovation Summit @ ASCRS 2019

Genentech Presentation on Groundbreaking Developments in AI & Imaging at OIS@ASRS 2019

Genentech Presentation on Groundbreaking Developments in AI & Imaging at OIS@ASRS 2019

AsclepiX Therapeutics - Innovation Showcase at Ophthalmology Innovation Summit @ ASRS 2019

AsclepiX Therapeutics – Innovation Showcase at Ophthalmology Innovation Summit @ ASRS 2019

Listen To The Podcast

OIS Podcast Episode #222: Allergan's Jag Dosanjh on AbbVie's Acquisition and What's Next

Allergan’s Jag Dosanjh on AbbVie’s Acquisition & What’s Next

August 20, 2019

OIS Podcast 220

Mitro Opens Up About Aerie’s Programs

July 10, 2019

OIS Podcast | Episode 219

Novartis’ Patrick Mooney Gives Inside Look on the Impact of Alcon Spin-Out, Bid to Acquire Xiidra

May 14, 2019

OIS-Episode218

Avedro CEO Reza Zadno Walks Us Through the Recent IPO, Reimbursement Wins, and Future Potential

April 24, 2019

OIS Podcast | Episode 217

Oculis CEO Riad Sherif Talks About Novartis, Alcon, and What’s Promising in His Company’s Pipeline

April 17, 2019

OIS Podcast | Episode 216

Oyster Point Pharma CEO Jeffrey Nau Highlights Details of the Company’s Recent B Round, Ponders IPO

April 10, 2019

genetics

Glaucoma Genetics: State of the Science

The State of the Art of Glaucoma Genetics

February 5, 2019

Can 2019 Be ‘Transformative’ for AGTC?

After XLRS Gene Therapy Disappoints, AGTC Looks to ‘Transformative Year’

January 16, 2019

What Relaxed Gene Therapy Oversight Means

Putting Relaxed NIH, FDA Oversight of Gene Therapies into Perspective

November 28, 2018

The Sweet Six: Recipients of the 2018 Ophthalmology Innovation Awards

The Sweet Six: Recipients of the 2018 Ophthalmology Innovation Awards

October 25, 2018

Gene Therapy Treatments Are Filling Some Companies’ Pipelines

Gene Therapy Treatments Are Filling Some Companies’ Pipelines

August 15, 2018

1
2
3
Next »

Emmett-Year-in-Review-2018

watch videos from ois tv

All
Companies To Watch

meet the speakers of ois@asrs 2019

Emmett Cunningham

Emmett T. Cunningham Jr., MD, PhD, MPH

Pravin Dugel, MD

Jay Duker, MD

Mark Humayun, MD, PhD

David Boyer, MD

Szilárd Kiss, MD

OIS Index

OIS Index Posts Modest Gain for Q2; Ophthalmic Market Leader Alcon Joins Index

OIS Index Delivers Stellar First-Quarter 2019 Performance

OIS Index Follows the Stock Market Lower in December

Market Rebounds in November; OIS Index Does Not

OIS Index Follows Stock Market Lower in October

Small Cap Stocks Lead the Way for OIS Index in September

Glaukos and STAAR Drive OIS Index into Record Territory

ois press

OIS-Why-Attend-Footer-2019[2206]

Ophthalmology Innovation Summit @ SECO Register

@oistweets

Tweets by @oistweets

most popular episodes

OIS 1 Year Podcast Anniversary

Year 1: What OIS Podcasts Were Most Popular? Part Two

OIS 1 Year Podcast Anniversary

Year 1: What OIS Podcasts Were Most Popular? Part One

OIS Podcast - Xiidra Prior to Shire: How SARcode Beat the Odds to Create a New Treatment for Dry Eye - Healthegy

Xiidra Prior to Shire: How SARcode Took on the Odds to Pursue a New Treatment for Dry Eye

OIS Podcast | Episode 198

With Positive Phase II Dry Eye Data in Hand, What’s Next for Aldeyra’s Promising Pipeline?